Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2701

1.

Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

Shaik AN, Ruterbusch JJ, Abdulfatah E, Shrestha R, Daaboul MHDF, Pardeshi V, Visscher DW, Bandyopadhyay S, Ali-Fehmi R, Cote ML.

Breast Cancer Res. 2018 Aug 9;20(1):91. doi: 10.1186/s13058-018-1027-6.

2.

Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers.

Osada T, Hartman ZC, Wei J, Lei G, Hobeika AC, Gwin WR, Diniz MA, Spector N, Clay TM, Chen W, Morse MA, Lyerly HK.

Breast Cancer Res. 2018 Aug 9;20(1):90. doi: 10.1186/s13058-018-1023-x.

3.

High mammographic density in women is associated with protumor inflammation.

Huo CW, Hill P, Chew G, Neeson PJ, Halse H, Williams ED, Henderson MA, Thompson EW, Britt KL.

Breast Cancer Res. 2018 Aug 9;20(1):92. doi: 10.1186/s13058-018-1010-2.

4.

Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study.

Borgquist S, Rosendahl AH, Czene K, Bhoo-Pathy N, Dorkhan M, Hall P, Brand JS.

Breast Cancer Res. 2018 Aug 9;20(1):93. doi: 10.1186/s13058-018-1026-7.

5.

Thyroid hormones and breast cancer association according to menopausal status and body mass index.

Ortega-Olvera C, Ulloa-Aguirre A, Ángeles-Llerenas A, Mainero-Ratchelous FE, González-Acevedo CE, Hernández-Blanco ML, Ziv E, Avilés-Santa L, Pérez-Rodríguez E, Torres-Mejía G.

Breast Cancer Res. 2018 Aug 9;20(1):94. doi: 10.1186/s13058-018-1017-8.

6.

Clonal relatedness in tumour pairs of breast cancer patients.

Biermann J, Parris TZ, Nemes S, Danielsson A, Engqvist H, Werner Rönnerman E, Forssell-Aronsson E, Kovács A, Karlsson P, Helou K.

Breast Cancer Res. 2018 Aug 9;20(1):96. doi: 10.1186/s13058-018-1022-y.

7.

Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study.

Puliti D, Zappa M, Giorgi Rossi P, Pierpaoli E, Manneschi G, Ambrogetti D, Ventura L, Mantellini P; DENSITY Working Group.

Breast Cancer Res. 2018 Aug 9;20(1):95. doi: 10.1186/s13058-018-1025-8.

8.

Correction to: Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in luminal B breast cancer.

Katchman BA, Tolgay Ocal I, Cunliffe HE, Chang YH, Hostetter G, Watanabe A, LoBello J, Lake DF.

Breast Cancer Res. 2018 Aug 8;20(1):89. doi: 10.1186/s13058-018-0998-7.

9.

Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.

Penkert J, Schmidt G, Hofmann W, Schubert S, Schieck M, Auber B, Ripperger T, Hackmann K, Sturm M, Prokisch H, Hille-Betz U, Mark D, Illig T, Schlegelberger B, Steinemann D.

Breast Cancer Res. 2018 Aug 7;20(1):87. doi: 10.1186/s13058-018-1011-1.

10.

Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.

Liang X, Vacher S, Boulai A, Bernard V, Baulande S, Bohec M, Bièche I, Lerebours F, Callens C.

Breast Cancer Res. 2018 Aug 7;20(1):88. doi: 10.1186/s13058-018-1007-x.

11.

Can novel technologies improve breast conserving surgery?

Pogue BW.

Breast Cancer Res. 2018 Aug 3;20(1):85. doi: 10.1186/s13058-018-1016-9. No abstract available.

12.

Nitric oxide deficiency and endothelial-mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice.

Smeda M, Kieronska A, Adamski MG, Proniewski B, Sternak M, Mohaissen T, Przyborowski K, Derszniak K, Kaczor D, Stojak M, Buczek E, Jasztal A, Wietrzyk J, Chlopicki S.

Breast Cancer Res. 2018 Aug 3;20(1):86. doi: 10.1186/s13058-018-1013-z.

13.

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.

Vreemann S, van Zelst JCM, Schlooz-Vries M, Bult P, Hoogerbrugge N, Karssemeijer N, Gubern-Mérida A, Mann RM.

Breast Cancer Res. 2018 Aug 3;20(1):84. doi: 10.1186/s13058-018-1019-6.

14.

Effect of exercise and/or reduced calorie dietary interventions on breast cancer-related endogenous sex hormones in healthy postmenopausal women.

de Roon M, May AM, McTiernan A, Scholten RJPM, Peeters PHM, Friedenreich CM, Monninkhof EM.

Breast Cancer Res. 2018 Aug 2;20(1):81. doi: 10.1186/s13058-018-1009-8. Review.

15.

Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.

Wang Y, Zhang J, Wu L, Liu W, Wei G, Gong X, Liu Y, Ma Z, Ma F, Thiery JP, Chen L.

Breast Cancer Res. 2018 Aug 2;20(1):83. doi: 10.1186/s13058-018-1018-7.

16.

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.

Diamond JR, Eckhardt SG, Pitts TM, van Bokhoven A, Aisner D, Gustafson DL, Capasso A, Sams S, Kabos P, Zolman K, Colvin T, Elias AD, Storniolo AM, Schneider BP, Gao D, Tentler JJ, Borges VF, Miller KD.

Breast Cancer Res. 2018 Aug 2;20(1):82. doi: 10.1186/s13058-018-1014-y.

17.

Correction to: Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.

Guttery DS, Hancox RA, Mulligan KT, Hughes S, Lambe SM, Howard Pringle J, Walker RA, Louise Jones J, Shaw JA.

Breast Cancer Res. 2018 Aug 1;20(1):80. doi: 10.1186/s13058-018-0997-8.

18.

Intracellular hypoxia measured by 18F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer.

Asano A, Ueda S, Kuji I, Yamane T, Takeuchi H, Hirokawa E, Sugitani I, Shimada H, Hasebe T, Osaki A, Saeki T.

Breast Cancer Res. 2018 Jul 27;20(1):78. doi: 10.1186/s13058-018-0970-6.

19.

The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer.

Jensen MB, Lænkholm AV, Nielsen TO, Eriksen JO, Wehn P, Hood T, Ram N, Buckingham W, Ferree S, Ejlertsen B.

Breast Cancer Res. 2018 Jul 27;20(1):79. doi: 10.1186/s13058-018-1012-0.

20.

Retraction Note: Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.

Li JT, Wang LF, Zhao YL, Yang T, Li W, Zhao J, Yu F, Wang L, Meng YL, Liu NN, Zhu XS, Gao CF, Jia LT, Yang AG.

Breast Cancer Res. 2018 Jul 25;20(1):77. doi: 10.1186/s13058-018-1021-z.

Supplemental Content

Loading ...
Support Center